pioglitazone has been researched along with diazepinylbenzoic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kadowaki, T | 1 |
| Horiuchi, A; Kagechika, H; Kamisaka, Y; Nakatsu, M; Okuma, E; Saeki, K; Uemura, I; Yasuda, K; Yasugi, E; Yuo, A | 1 |
| Eguchi, J; Hida, A; Hida, K; Inoue, K; Kagechika, H; Kanzaki, M; Katayama, A; Makino, H; Murakami, K; Nakatsuka, A; Ogawa, D; Terami, T; Teshigawara, S; Wada, J | 1 |
1 review(s) available for pioglitazone and diazepinylbenzoic acid
| Article | Year |
|---|---|
[A trend of insulin sensitizer which is under development].
Topics: Animals; Benzoates; Biphenyl Compounds; Clinical Trials as Topic; Drug Design; Humans; Hypoglycemic Agents; Insulin Resistance; Pioglitazone; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Thiazoles; Thiazolidinediones; Transcription Factors | 2001 |
2 other study(ies) available for pioglitazone and diazepinylbenzoic acid
| Article | Year |
|---|---|
Peroxisome proliferator-activated receptor gamma ligands stimulate myeloid differentiation and lipogenensis in human leukemia NB4 cells.
Topics: Adipocytes; Anilides; Benzoates; Biphenyl Compounds; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Fatty Acid-Binding Proteins; Humans; Ligands; Lipids; Myeloid Cells; Pioglitazone; PPAR gamma; Prostaglandin D2; Thiazolidinediones; Tretinoin; Triglycerides; Tumor Cells, Cultured; Up-Regulation | 2006 |
RXR antagonism induces G0 /G1 cell cycle arrest and ameliorates obesity by up-regulating the p53-p21(Cip1) pathway in adipocytes.
Topics: Adipocytes; Animals; Anti-Obesity Agents; Benzoates; Biphenyl Compounds; Cell Proliferation; Cell Size; Cells, Cultured; Cyclin-Dependent Kinase Inhibitor p21; Diabetes Mellitus, Type 2; Disease Models, Animal; G1 Phase Cell Cycle Checkpoints; Humans; Hypertrophy; Hypoglycemic Agents; Kidney Glomerulus; Male; Obesity; Pioglitazone; PPAR gamma; Rats; Rats, Inbred OLETF; Resting Phase, Cell Cycle; Retinoid X Receptors; RNA Interference; Signal Transduction; Thiazolidinediones; Time Factors; Transfection; Tumor Suppressor Protein p53; Up-Regulation | 2012 |